Koers Vaxcell-Bio Therapeutics Co., Ltd.
Aandelen
A323990
KR7323990002
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16.050 KRW | -1,53% | -4,41% | -28,51% |
Omzet 2022 | - | Omzet 2023 | 13,72 18,87K 12,84 | Marktkapitalisatie | 516 mld. 709.875 mld. 483 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -6,82 mld. -9.386 mld. -6,39 mld. | Nettowinst (verlies) 2023 | -10,27 mld. -14.129 mld. -9,61 mld. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 20,29 mld. 27.899 mld. 18,98 mld. | Nettoliquiditeiten 2023 | 49,69 mld. 68.327 mld. 46,48 mld. | EV/omzet 2023 | 33.994.130.725 x |
K/w-verhouding 2022 |
-63,5
x | K/w-verhouding 2023 |
-42,8
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 76,05% |
1 dag | -1,53% | ||
1 week | -4,41% | ||
Lopende maand | -22,46% | ||
1 maand | -31,26% | ||
3 maanden | -15,08% | ||
6 maanden | -23,42% | ||
Lopend jaar | -28,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joon-Haeng Lee
CEO | Chief Executive Officer | 64 | - |
Jae-Jung Lee
CEO | Chief Executive Officer | 60 | 18-02-10 |
Taek-Gun Oh
AUD | Comptroller/Controller/Auditor | 48 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sung-Chang Jung
BRD | Director/Board Member | 67 | - |
Jae-Jung Lee
CEO | Chief Executive Officer | 60 | 18-02-10 |
Joon-Haeng Lee
CEO | Chief Executive Officer | 64 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 4 M€ | -4,41% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 16.050 | -1,53% | 131 019 |
24-04-24 | 16.300 | -5,23% | 1 142 262 |
23-04-24 | 17.200 | +0,76% | 101 105 |
22-04-24 | 17.070 | +2,28% | 89 406 |
19-04-24 | 16.690 | -0,60% | 94 464 |
slotkoers Korea S.E., 25 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-28,51% | 269 mln. | |
-2,18% | 103 mld. | |
+0,80% | 95,71 mld. | |
+2,10% | 22,02 mld. | |
-16,71% | 20,9 mld. | |
-9,00% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-14,86% | 15,52 mld. | |
+3,05% | 13,86 mld. | |
+34,51% | 12,04 mld. |